We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+30.69%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$5.45B
AUM Growth
+$454M
(+9.1%)
Cap. Flow
-$312M
Cap. Flow
% of AUM
-5.73%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
130
New
20
Increased
22
Reduced
29
Closed
17
Top Buys
| 1 |
ArriVent BioPharma
AVBP
|
+$61.1M |
| 2 |
Cytokinetics
CYTK
|
+$52.8M |
| 3 |
Esperion Therapeutics
ESPR
|
+$33.3M |
| 4 |
Merck
MRK
|
+$32.2M |
| 5 |
Q32 Bio
QTTB
|
+$31M |
Top Sells
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$147M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$93.5M |
| 3 |
United Therapeutics
UTHR
|
+$84.9M |
| 4 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
+$71.7M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$69.9M |
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $340M | 6.24% |
2,718,735
| – | – |
|
2
Eli Lilly
LLY
$1.02T
| $281M | 5.15% |
360,800
-4,600
| -1% | -$3.27M |
|
3
Edgewise Therapeutics
EWTX
$4.25B
| $274M | 5.03% |
15,021,721
+454,545
| +3% | +$7.22M |
|
4
Boston Scientific
BSX
$64.4B
| $224M | 4.12% |
3,273,000
-33,800
| -1% | -$2.17M |
|
5
Intuitive Surgical
ISRG
$138B
| $197M | 3.61% |
493,100
-5,900
| -1% | -$2.23M |
|
6
Biogen
BIIB
$28.6B
| $194M | 3.57% |
900,900
+73,300
| +9% | +$17.2M |
|
|
7
Merck
MRK
$305B
| $174M | 3.19% |
1,316,000
+261,000
| +25% | +$32.2M |
|
8
Janux Therapeutics
JANX
$971M
| $161M | 2.96% |
4,275,553
+957,626
| +29% | +$20.9M |
|
9
Enliven Therapeutics
ELVN
$3.71B
| $158M | 2.91% |
8,998,338
| – | – |
|
10
Tenet Healthcare
THC
$16.4B
| $123M | 2.26% |
1,173,300
-51,100
| -4% | -$4.59M |
|
11
BioMarin Pharmaceuticals
BMRN
$11.4B
| $112M | 2.05% |
1,278,500
-292,910
| -19% | -$26.2M |
|
|
ALPN
12
DELISTED
Alpine Immune Sciences Inc
ALPN
| $106M | 1.95% |
2,680,496
+145,251
| +6% | +$4.29M |
|
13
Disc Medicine
IRON
$2.86B
| $106M | 1.95% |
1,702,237
| – | – |
|
14
Stryker
SYK
$121B
| $96.3M | 1.77% |
269,000
| – | – |
|
15
ARS Pharmaceuticals
SPRY
$749M
| $94.4M | 1.73% |
9,240,887
| – | – |
|
16
Sarepta Therapeutics
SRPT
$1.87B
| $90.3M | 1.66% |
697,500
| – | – |
|
17
Ionis Pharmaceuticals
IONS
$8.93B
| $87.3M | 1.6% |
2,013,033
-51,764
| -3% | -$2.47M |
|
18
Elevance Health
ELV
$83.5B
| $87.2M | 1.6% |
168,100
+26,600
| +19% | +$13.2M |
|
19
Xtant Medical Holdings
XTNT
$61.7M
| $85.5M | 1.57% |
73,114,592
| – | – |
|
20
Evolent Health
EVH
$664M
| $85.4M | 1.57% |
2,605,615
-140,917
| -5% | -$4.5M |
|
|
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
| $84M | 1.54% |
1,707,331
-1,512,028
| -47% | -$69.9M |
|
22
Keros Therapeutics
KROS
$209M
| $84M | 1.54% |
1,268,734
| – | – |
|
23
Natera
NTRA
$39.5B
| $82.3M | 1.51% |
899,431
-55,050
| -6% | -$4.14M |
|
24
Thermo Fisher Scientific
TMO
$199B
| $76.7M | 1.41% |
132,000
-11,800
| -8% | -$6.62M |
|
|
APLS
25
DELISTED
Apellis Pharmaceuticals
APLS
| $76.3M | 1.4% |
1,297,800
+375,600
| +41% | +$23.9M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM